Sachs, Volkmar; Szirmai, Endre
January 1970
Angiology;Jan1970, Vol. 21 Issue 1, p1
Academic Journal
Reaction of immune antiplasminogen with plasminogen in human plasma precipitates a part of the plasminogen but does not inhibit its fibrinolytic activity. This finding is discussed with respect to fibrinolytic and antifibrinolytic therapy, to investigations of properties and structure of plasminogen and to the meaning of antibody formation and antigen antibody reactions.


Related Articles

  • Premature Senescence and Increased TGFβ Signaling in the Absence of Tgif1. Zerlanko, Brad J.; Bartholin, Laurent; Melhuish, Tiffany A.; Wotton, David // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Transforming growth factor β (TGFβ) signaling regulates cell cycle progression in several cell types, primarily by inducing a G1 cell cycle arrest. Tgif1 is a transcriptional corepressor that limits TGFβ responsive gene expression. Here we demonstrate that primary mouse embryo...

  • Plasminogen Activator Inhibitor-1 4G/5G Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis. Yan-yan Li // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: The polymorphism of plasminogen activator inhibitor-1 (PAI-1) 4G/5G gene has been indicated to be correlated with coronary artery disease (CAD) susceptibility, but study results are still debatable. Objective and Methods: The present meta-analysis was performed to investigate the...

  • Long-term Behavior of Endothelial and Coagulation Markers in Eisenmenger Syndrome. Caramuru, Lúcia H.; Lopes, Antonio Augusto; Maeda, Nair Y.; Aiello, Vera D.; Filho, Cyrillo Cavalheiro // Clinical & Applied Thrombosis/Hemostasis;Apr2006, Vol. 12 Issue 2, p175 

    The long-term behavior of endothelial markers was studied in patients with Eisenmenger syndrome who were subjected to conventional therapy (no vasodilators) and observed for 18 months. Biochemical markers were analyzed comparatively in patients with class II or III symptoms (group 1, n=10) and...

  • Increasing tPA Activity in Astrocytes Induced by Multipotent Mesenchymal Stromal Cells Facilitate Neurite Outgrowth after Stroke in the Mouse. Hongqi Xin; Yi Li; Li Hong Shen; Xianshuang Liu; Xinli Wang; Jing Zhang; Pourabdollah-Nejad D, Siamak; Chunling Zhang; Li Zhang; Hao Jiang; Zheng Gang Zhang; Chopp, Michael // PLoS ONE;2010, Vol. 5 Issue 2, p1 

    We demonstrate that tissue plasminogen activator (tPA) and its inhibitors contribute to neurite outgrowth in the central nervous system (CNS) after treatment of stroke with multipotent mesenchymal stromal cells (MSCs). In vivo, administration of MSCs to mice subjected to middle cerebral artery...

  • Administration of Tissue Plasminogen Activator (tPA) during an Orthotopic Heart Transplant. Silverman, Richard; Fuhrman, Thomas; Barron, Michael E.; Ricci, Marco; Panos, Anthony; Sultan, Ali // Internet Journal of Anesthesiology;2010, Vol. 23 Issue 2, p9 

    A 56yr old female with nonischemic cardiomyopathy and a remote unsubstantited history of lupus anticoagulant presented for orthotopic heart transplant. During the decannulation, the cardiopulmonary pass pump showed signs of clot. Simultaneously Bispectral Analysis neurological monitoring...

  • The effects of the overexpression of recombinant uncoupling protein 2 on proliferation, migration and plasminogen activator inhibitor 1 expression in human vascular smooth muscle cells. Park, J-Y.; Park, K-G.; Kim, H-J.; Kang, H-G.; Ahn, J.D.; Kim, H-S.; Kim, Y.M.; Son, S.M.; Kim, I.J.; Kim, Y.K.; Kim, C.D.; Lee, K-U.; Lee, I-K. // Diabetologia;May2005, Vol. 48 Issue 5, p1022 

    Aims/hypothesis: Increased oxidative stress in vascular smooth muscle cells (VSMCs) has been implicated in the pathogenesis of accelerated atherosclerosis in patients with diabetes mellitus. Uncoupling protein 2 (UCP-2) is an important regulator of intracellular reactive oxygen species (ROS)...

  • Isolation of Tissue Plasminogen Activator from Skin Lesions with Allergic Vasculitis. Toki, Naotika; Tsushima, Hirofumi; Yamasaki, Masahiro; Yamasaki, Reiko; Yamura, Takuso // Journal of Investigative Dermatology;Jan1982, Vol. 78 Issue 1, p18 

    A tissue plasminogen activator was extracted from skin lesions with allergic vasculitis and purified by successive column chromatography on Sephadex G-200, DEAE-cellulose, Hydroxyaptite-cellulose and polyacrylamide gel electrophoresis. By these procedures, 160 μg of enzyme with a specific...

  • Turning a stroke into a TIA: curative thrombolysis with combined intravenous and intra-arterial tPA. Gladstone, David J.; Aviv, Richard I.; Jahromi, Babak; Black, Sandra E.; Baryshnik, Devra; Caratao, Rochelle; Fox, Allan J. // CJEM: Canadian Journal of Emergency Medicine;Jan2006, Vol. 8 Issue 1, p54 

    Intravenous tissue plasminogen activator (tPA) is standard treatment for eligible patients with acute ischemic stroke, but may be less effective for very severe strokes caused by proximal intracranial artery occlusions. We report the case of a woman with a devastating stroke who recovered...

  • Intrathrombus Administration of Tissue Plasminogen Activator in Acute Cerebrovascular Occlusion. Frey, James L.; Greene, Karl A.; Khayata, Mazen H.; Dean, Bruce L.; Hodak, John A.; Spetzler, Robert F. // Angiology;Aug1995, Vol. 46 Issue 8, p649 

    Intraarterial thrombolysis for acute cerebrovascular occlusion has achieved recanalization at a 50-90% rate. Clinical outcome has been unpredictable. The authors sought to test the hypothesis that intrathrombus administration of recombinant tissue plasminogen activator (rt-PA) would improve...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics